BioWorld - Wednesday, December 6, 2023
See today's BioWorld
X

Upgrade your daily dose of biopharma and medtech news

Subscribe to BioWorld™ news services

See subscription options
To read the full story, subscribe or sign in.

Through Beigene, Amgen helps awaken the sleeping giant; $2.7B cash investment

Nov. 4, 2019
By Lee Landenberger and Elise Mak
No Comments
When the time was right to make a powerful Western biotech welcome in China, Beigene Ltd. was ready when Amgen Inc. came calling. Its massive $2.7 billion cash equity investment in Beigene buys Amgen an oncology footprint in China.
BioWorld Deals and M&A